GCNT3, aa410-422 (Gucosaminyl (N-acetyl) transferase 3, mucin type, C2/4GnT, C2GnT-M, C2GnT2, GnT-M, beta1, 6-N-acetyl glucosaminyl transferase) (Control Peptide)[GCNT3, aa410-422]

General information
 

Name:
GCNT3, aa410-422 (Gucosaminyl (N-acetyl) transferase 3, mucin type, C2/4GnT, C2GnT-M, C2GnT2, GnT-M, beta1, 6-N-acetyl glucosaminyl transferase) (Control Peptide)[GCNT3, aa410-422]
Size:
NA
Catalog no:
MBS659155
Price:
5 EUR
 

Additional extra details
 

  • Products_type

    Peptide

    Tissue

    control

    Description

    N terminal acetylation or CH3CO as epigenetic regulation of GCNT3, aa410-422 (Gucosaminyl (N- ) transferase 3, mucin C2/4GnT, C2GnT-M, C2GnT2, GnT-M, beta1, 6-N- glucosaminyl transferase) (Control Peptide)[GCNT3, aa410-422] by NATs.Isotype or positive controls by peptides, antibodies and deactivated samples.Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.